Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)
Notice of Special Interest (NOSI): Interventions to promote mental well-being in populations that experience health disparities through social, cultural, and environmental connectedness (First available due date: Feb 5)
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed) (Earliest Submission Date: Jan 14)
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) (Earliest Submission Date: Jan 7
Notice of Special Interest (NOSI): Palliative Care in the Care Continuum among Persons with Serious Heart, Lung, Blood and Sleep (HLBS) Diseases and their Caregivers (First Available Due Date: Feb 5)
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 – Clinical Trial Required) (Earliest Submission Date: Jan 5)
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) (Earliest Submission Date: Feb 1)
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) (Earliest Submission Date: Feb 1)
Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional) (Earliest Submission Date: Jan 28)
Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth (Closes Dec 1)
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 – Clinical Trials Not Allowed) (Open Date (Earliest Submission Date: Jan 5)
Research Grants to Identify Effective Community-Based Strategies for Overdose Prevention (R01) Department of Health and Human Services (Closes Dec 1)
Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders (Expiration Date: Jan 8)
Research Opportunity Announcement (ROA): NIH All of Us Engagement, Communications, and Enrollment Partnerships
Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 – Clinical Trial Required)
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
CE-24-011 – Grants to Support New Investigators in Conducting Research Related to Understanding Drug Use and Overdose Risk and Protective Factors (K01) (Current Closing Date for Applications: Dec 1)
Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth (Current Closing Date for Applications: Dec 1)
Research Grants to Identify Effective Community-Based Strategies for Overdose Prevention (R01) (Current Closing Date for Applications: Dec 1)
Research Grants for Preventing Violence and Violence Related Injury (R01) Department of Health and Human Services (Current Closing Date for Applications: Dec 1)
Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) Department of Health and Human Services (Current Closing Date for Applications: Dec 1)
Rigorous Evaluation of Policies for their Impacts on the Primary Prevention of Multiple Forms of Violence (Current Closing Date for Applications: Dec 1)
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) (Application Due Dates: Jan 16)
R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed) (Open Date – Earliest Submission Date: Nov 1
Grants to Support New Investigators in Conducting Research Related to Understanding Drug Use and Overdose Risk and Protective Factors (K01) (Current Closing Date for Applications: Dec 1)
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed) (Open Date – Earliest Submission Date: July 14)
National Poverty Fellows Program Call For Applications For The 2024–2025 Fellowship Year – Due 11/27/2023, 11:59 PM CT
Career Enhancement Award to Advance the Study of Intimate Partner Violence (IPV) in the Context of Maternal Morbidity and Mortality Research (K18 Clinical Trial Not Allowed) (Open Date – Earliest Submission Date: Nov 1
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Required) (Estimated Publication Date of Notice of Funding Opportunity: Dec 14)
Request for Information (RFI) on the need for research studies to evaluate potential effects of types of blood pressure reducing agents on the development of mild cognitive impairment and dementia
Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders (First Available Due Date: Oct 5)
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)